ABC | Volume 110, Nº5, May 2018

Review Article Ybarra et al CTO PCI Review Arq Bras Cardiol. 2018; 110(5):476-483 This is an open-access article distributed under the terms of the Creative Commons Attribution License 55. Werner GS. A Randomized multicentre trial to evaluate the utilization of revascularizationoroptimalmedicaltherapyforthetreatmentofchronictotal coronary occlusions (EuroCTO). Euro PCR Abstracts. Paris (France); 2017. 56. Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994;90(6):2725-30. 57. Christakopoulos GE, Christopoulos G, Karmpaliotis D, Alaswad K, Yeh RW, Jaffer FA, et al. Predictors of excess patient radiation exposure during chronic total occlusion coronary intervention: insights froma contemporary multicentre registry. Can J Cardiol. 2017;33(4):478-84. 58. Balter S, Brinkman M, Kalra S, Nazif T, Parikh M, Kirtane AJ, et al. Novel radiation dose reduction fluoroscopic technology facilitates chronic total occlusion percutaneous coronary interventions. EuroIntervention. 2017;13(12):e1468-e1474. 59. YbarraLF,DautovR,GibratC,DandonaS,RinfretS.Mid-termangina-related quality of life benefits after percutaneous coronary intervention of chronic total occlusions. Can J Cardiol. 2017;33(12):1668-74. 60. Mashayekhi K, Neuser H, Kraus A, Zimmer M, Dalibor J, Akin I, et al. Successful percutaneous coronary intervention improves cardiopulmonary exercise capacity in patients with chronic total occlusions. J AmColl Cardiol. 2017;69(8):1095-6. 61. Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, et al. Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion andwell-developed collateral circulation. JACC Cardiovasc Interv. 2015;8(2):271-9. 62. Tomasello SD, Boukhris M, Giubilato S, Marza F, Garbo R, ContegiacomoG, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36(45):3189-98. 63. Henriques JP, Hoebers LP, Ramunddal T, Laanmets P, Eriksen E, Bax M, et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622-32. 64. Park S-J. Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO). American College of Cardiology’s 66th Annual Scientific Session& Expo;Washington, DC, USA2017. 65. Gao L, Wang Y, Liu Y, Cao F, Chen Y. Long-term clinical outcomes of successful revascularization with drug-eluting stents for chronic total occlusions: A systematic review and meta-analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2017;89(S1):574-81. 66. Hannan EL, Zhong Y, Jacobs AK, Stamato NJ, Berger PB, Walford G, et al. Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions:Characteristics,Success,andOutcomes.Circulation Cardiovascular interventions. 2016;9(5):e003586. 483